199 related articles for article (PubMed ID: 19672917)
1. Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation.
Keller M; Teng S; Bernhardt G; Buschauer A
ChemMedChem; 2009 Oct; 4(10):1733-45. PubMed ID: 19672917
[TBL] [Abstract][Full Text] [Related]
2. Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.
Weiss S; Keller M; Bernhardt G; Buschauer A; König B
Bioorg Med Chem; 2008 Nov; 16(22):9858-66. PubMed ID: 18851917
[TBL] [Abstract][Full Text] [Related]
3. Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.
Keller M; Kaske M; Holzammer T; Bernhardt G; Buschauer A
Bioorg Med Chem; 2013 Nov; 21(21):6303-22. PubMed ID: 24074877
[TBL] [Abstract][Full Text] [Related]
4. Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist.
Keller M; Pop N; Hutzler C; Beck-Sickinger AG; Bernhardt G; Buschauer A
J Med Chem; 2008 Dec; 51(24):8168-72. PubMed ID: 19053784
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist.
Schneider E; Keller M; Brennauer A; Hoefelschweiger BK; Gross D; Wolfbeis OS; Bernhardt G; Buschauer A
Chembiochem; 2007 Nov; 8(16):1981-8. PubMed ID: 17876753
[TBL] [Abstract][Full Text] [Related]
6. Application of the guanidine-acylguanidine bioisosteric approach to argininamide-type NPY Y₂ receptor antagonists.
Pluym N; Brennauer A; Keller M; Ziemek R; Pop N; Bernhardt G; Buschauer A
ChemMedChem; 2011 Sep; 6(9):1727-38. PubMed ID: 21692185
[TBL] [Abstract][Full Text] [Related]
7. Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools.
Keller M; Erdmann D; Pop N; Pluym N; Teng S; Bernhardt G; Buschauer A
Bioorg Med Chem; 2011 May; 19(9):2859-78. PubMed ID: 21493077
[TBL] [Abstract][Full Text] [Related]
8. [(3)H]UR-PLN196: a selective nonpeptide radioligand and insurmountable antagonist for the neuropeptide Y Y(2) receptor.
Pluym N; Baumeister P; Keller M; Bernhardt G; Buschauer A
ChemMedChem; 2013 Apr; 8(4):587-93. PubMed ID: 23361914
[TBL] [Abstract][Full Text] [Related]
9. Preparation of fluorescent nonpeptidic neuropeptide Y receptor ligands: analogues of the quinazoline-type anti-obesity Y5 antagonist CGP 71683A.
Li L; Mayer M; Schneider E; Schreiber E; Bernhardt G; Peng S; Buschauer A
Arch Pharm (Weinheim); 2003 Dec; 336(12):585-90. PubMed ID: 14677152
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
[TBL] [Abstract][Full Text] [Related]
12. N(G)-Acyl-argininamides as NPY Y(1) receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity.
Weiss S; Keller M; Bernhardt G; Buschauer A; König B
Bioorg Med Chem; 2010 Sep; 18(17):6292-304. PubMed ID: 20688523
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.
Beauverger P; Rodriguez M; Nicolas JP; Audinot V; Lamamy V; Dromaint S; Nagel N; Macia C; Léopold O; Galizzi JP; Caignard DH; Aldana I; Monge A; Chomarat P; Boutin JA
Cell Signal; 2005 Apr; 17(4):489-96. PubMed ID: 15601626
[TBL] [Abstract][Full Text] [Related]
15. Toward Labeled Argininamide-Type NPY Y1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304.
Keller M; Schindler L; Bernhardt G; Buschauer A
Arch Pharm (Weinheim); 2015 Jun; 348(6):390-8. PubMed ID: 25884646
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
Rodriguez M; Audinot V; Dromaint S; Macia C; Lamamy V; Beauverger P; Rique H; Imbert J; Nicolas JP; Boutin JA; Galizzi JP
Biochem J; 2003 Feb; 369(Pt 3):667-73. PubMed ID: 12398768
[TBL] [Abstract][Full Text] [Related]
17. Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells.
Pop N; Igel P; Brennauer A; Cabrele C; Bernhardt GN; Seifert R; Buschauer A
J Recept Signal Transduct Res; 2011 Aug; 31(4):271-85. PubMed ID: 21745157
[TBL] [Abstract][Full Text] [Related]
18. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes.
Schneider E; Mayer M; Ziemek R; Li L; Hutzler C; Bernhardt G; Buschauer A
Chembiochem; 2006 Sep; 7(9):1400-9. PubMed ID: 16888730
[TBL] [Abstract][Full Text] [Related]
19. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG
Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers.
Russo O; Berthouze M; Giner M; Soulier JL; Rivail L; Sicsic S; Lezoualc'h F; Jockers R; Berque-Bestel I
J Med Chem; 2007 Sep; 50(18):4482-92. PubMed ID: 17676726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
